(Las Vegas, Nevada, United States),”DelveInsight’s “Sly Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sly Syndrome, historical and forecasted epidemiology as well as the Sly Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Sly Syndrome Overview
The sly syndrome is caused by a deficiency of the enzyme beta-glucuronidase, and it was the first MPS for which the altered gene was localized to an autosome chromosome, the long arm of the chromosome. Sly syndrome, also called mucopolysaccharidosis type VII (MPS-VII), is an autosomal recessive lysosomal storage disease caused by a deficiency of the enzyme β-glucuronidase. This enzyme is responsible for breaking down large sugar molecules called glycosaminoglycans (AKA GAGs, or mucopolysaccharides). The inability to break down GAGs leads to a buildup in many tissues and organs of the body. The severity of the disease can vary widely.
Sly Syndrome Epidemiological Insights
MPS-VII is one of the rarest forms of MPS. It occurs in less than 1 in 250,000 births. As a family, MPS diseases occur in 1 in 25,000 births, and the larger family of lysosomal storage diseases occur in 1 out of 7,000 to 8,000 births
Leading Companies Working in the Sly Syndrome Market
-
UltraGenx Pharma
-
CentoGene GmBh
And many others
Leading Therapies Working in the Sly Syndrome Market
-
UX003
-
Placebo
And many others
Learn more about the Sly Syndrome Key companies and emerging therapies
Scope of the Sly Syndrome Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, Japan]
Key Sly Syndrome Encephalitis Companies: Novartis, Astellas, AstraZeneca, Merck, Sanofi, TmunityTherapeutics, Xencor Inc, and many others
Hormone Refractory Prostate Cancer Encephalitis Therapies: Patupilone, Patupilone, DocetaxelOlaparib, Abiraterone Acetate, PHA-739358, Enzalutamide, and many others.
Therapeutic Assessment: Sly Syndrome current marketed and emerging therapies
Sly Syndrome Market Dynamics: Sly Syndrome Market Drivers and Barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Sly Syndrome Encephalitis Market Access, and Reimbursement
Table of Contents
1. Sly Syndrome Encephalitis Market Key Insights
2. Sly Syndrome Encephalitis Market Report Introduction
3. Sly Syndrome Market Overview at a Glance
4. Sly Syndrome Encephalitis Market Executive Summary
5. Disease Background and Overview
6. Sly Syndrome Treatment and Management
7. Sly Syndrome Epidemiology and Patient Population
8. Patient Journey
9. Sly Syndrome Emerging Drugs
10. 7MM Sly Syndrome Market Analysis
11. Sly Syndrome Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Sly Syndrome Encephalitis Market Drivers
15. Sly Syndrome Encephalitis Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Stay ahead in the competition by leveraging insights on Sly Syndrome
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services